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APPROPRIATE REGULATION OF 
ANTIBIOTICS IN liVESTOCK FEED 
ROBYN L. GOFORTH* 
CAROL R. GOFORTH** 
Abstract: For decades, antibiotics have been widely used, saving lives 
and reducing suffering. Such drugs are routinely employed among both 
human and farm animal populations. However, scientific data now links 
the use of antibiotics at sub therapeutic levels in livestock feed to the 
spread of antibiotic resistant bacteria in the human population. Mter 
examining the current research, this Article concludes that despite 
short-term economic benefits associated with the widespread use of 
antibiotics in agriculture, the risk to human health justifies a change in 
policy. This Article recommends a number of steps to minimize the 
spread of antibiotic resistance. The primary changes would be to phase 
out the use of antibiotics as livestock feed additives, and to refuse to 
approve new drugs for this purpose. In either instance, this use would 
be permissible if the drug sponsor provides convincing evidence that 
the agricultural use of its particular antibiotic presents no appreciable 
risk to human health. 
INTRODUCTION 
The headlines are sensational enough that it wouldn't be surpris-
ing to see them in the most notorious supermarket tabloids. l The sto-
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1 See, e.g., Zosi Kmietowicz, Superbugs are Beating at the Gates, NEW SCIENTIST (July 17, 
1999), available at http://www.newscientist.com/ns/19990717 /newsstoryI2.html; Leading 
Superbugs Develop Dramatic Resistance to the Newest Antibiotics, U. OF TORONTO NEWS & EVENTS 
(July 21, 1999), available at http://www.newsandevents.utoronto.ca/bin/19990721.asp; 
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ries behind the headlines are scary enough that they might be the 
plot of a horror movie.2 Unfortunately, it is often the scientific press 
that is reporting on the spread of antibiotic-resistant bacteria,!! and 
the threat to human health and life is very real and growing.4 
The increase in public awareness about the spread of antibiotic-
resistant bacteria has been occasioned by a significant increase in the 
number of reported cases of human illness associated with antibiotic 
resistance.5 Studies show that infectious disease mortality rates have 
risen nearly 60%,6 with the Centers for Disease Control (CDC) esti-
mating that more than half of the infection-related deaths involve re-
sistant bacteria.7 
Dubbed "super-bugs" in the popular press,s multi-drug resistant 
bacteria are becoming more and more common. Newspapers and 
magazines carry stories of bacterial infections that do not respond to 
the antibiotics typically prescribed to control them.9 As one legal 
commentator observed, "[m] any of the killer diseases of the past such 
as tuberculosis, typhoid fever, diphtheria, and pneumonia have re-
2 One recent news story cites an "alarming" spread of drug-resistant bacteria that can 
"kill people with weak immune systems." Day, supra note 1. Another draws parallels be-
tween the spread of antibiotic-resistant organisms and the "historical scourge known as the 
bubonic plague [that] killed up to one-third of Europe's population in the 1300s." Nor-
denberg, supra note 1. See generally LAURIE GARRETT, THE COMING PLAGUE (1994) (a re-
cent book on the subject drawing similar parallels) . 
3 Antibiotic resistance refers to "a property of bacteria that confers the capacity to in-
activate or exclude antibiotics, or a mechanism that blocks the inhibitory or killing effects 
of antibiotics, leading to survival despite exposure." USDA, ANTIMICROBIAL RESISTANCE 
ISSUES IN ANIMAL AGRICULTURE 1 (Dec. 1999) [hereinafter USDA REpORT]. For a review 
of some of the scientific articles on the subject, see infra Part III of this article. 
4 'The cause of bacterial reemergence as a threat to human health and life is the 
abuse of the 'miracle drugs,'" John W. Harrison & Timothy A. Svec, The Beginning of the 
End of the Antibiotic Era? Part l The Probkm: Abuse of the "Miracle Drugs," 29(3) QuINTES-
SENCE INT'L 151, 151 (1998) [hereinafter Harrison, Part 1]. 
5 NAT'L RESEARCH COUNCIL, BOARD ON AGRICULTURE, THE USE OF DRUGS IN FOOD 
ANIMALS, BENEFITS AND RISKS 3 (1999). 
6 Robert W. Pinner et al., Trends in Infectious Disease Mortality in the United States, 275 
JAMA 189,190 (1996). 
7 Leslie Alan Horvitz, It's a War to Restore Antibiotics, INSIGHT ON THE NEWS, Mar. 18, 
1996, at 38, cited in Michael Misocky, Comment, The Epidemic of Antibiotic Resistance: A Legal 
Remedy to Eradicate the "Bugs" in the Treatment of Infectious Diseases, 30 AKRON L. REv. 733, 737 
n.22 (1997). 
8 See supra note 1. 
9 Two recent student-written law review articles have also addressed the problem of an-
tibiotic-resistant bacteria. See generally Scott B. Markow, Note, Penetrating the Walls of Drug-
Resistant Bacteria: A Statutory Prescription to Combat Antibiotic Misuse, 87 GEO. LJ. 531 (1998); 
Misocky, supra note 7. Both of these articles, however, focus solely on the over-prescription 
of antibiotics. 
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turned to wreak havoc as bacteria are increasingly resistant to antibi-
oticS."IO While antibiotics were once regarded as an unending miracle 
of modern medicine ,11 we are fast approaching a time when the mira-
cle may come to an end.12 
While there are doubtless many factors contributing to the 
spread of multi-resistant bacteria, one factor appears to be the wide-
spread addition of antibiotics to livestockI3 feed. A wide range of anti-
biotics are currently added, in sub therapeutic amounts,14 to animal 
feeds. 15 A growing volume of research suggests that this practice is 
having devastating and potentially irreversible effects on the viability 
of antibiotics as agents to effectively treat diseases in human beings, 
but the legal community appears to be lagging far behind scientific 
experts in calling for an end to this practice in the United States. 
The first section of this article will provide a brief introduction to 
the mechanisms of antibiotic resistance in bacteria and the risks to 
human health posed by this growing phenomenon. The next section 
will examine current agricultural practices with regard to the use of 
antibiotics in subtherapeutic amounts, including an analysis of the 
beneficial results attributed to these practices. It will then consider 
whether existing research on antibiotic resistance that identifies a link 
10 Simon Midgely, Old Killers Resisting Arrest: Diseases Last Common in the 19th Century 
Have Returned with an Added Danger-the Prospect of an Antibiotic Resistant Super Bug, TIMES 
HIGHER EDUCATION SUPPLEMENT, July 19,1996, at 20, cited in Misocky, supra note 7, at 738. 
11 Stuart B. Levy, a professor of molecular biology and microbiology at the Tufts Uni-
versity School of Medicine, has described this phenomenon as follows: 
Ever since antibiotics became widely available in the 1940s, they 
have been hailed as miracle drugs-magic bullets able to eliminate 
bacteria without doing much harm to the cells of treated individu-
als. Yet with each passing decade, bacteria that defY not only single 
but multiple antibiotics-and therefore are extremely difficult to 
control-have become increasingly common. 
Stuart B. Levy, The Challenge of Antibiotic Resistance, 278 SCIENTIFIC AMERICAN 46, need pin-
point cite (Mar. 1998), available at http://www.sciam.com/1998/0398issue/0398Ievy.html 
[hereinafter Levy, The Challenge]. 
12 At least 3 strains of bacteria capable of causing life-threatening illnesses in human 
beings have already been demonstrated to be resistant to every currently available antibi-
otic. Levy, The Challenge, supra note 11, at 46. ( 
13 Although the term "livestock" may have a more limited meaning in other contexts, 
this article uses the term to mean any farm animal or poultry raised for food or food pro-
duction (such as dairy cows or laying hens). 
14 Despite the fact that differing drugs must normally be administered at differing lev-
els in order to have demonstrable therapeutic effects, the Food and Drug Administration 
rather arbitrarily defined a subtherapeutic concentration of antibiotics as an amount 
added to feed at a concentration of <200 g/t. NAT'L RESEARCH COUNCIL, supra note 5, at 
28. 
15 See infra Part II of this article. 
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between the use of livestock feed and risks to human health is 
sufficiently convincing so as to justify a change in policy. The final sec-
tion of this Article suggests legal steps which should be taken to en-
sure the appropriate use of antibiotics in the agricultural community. 
I. THE MECHANISMS OF ANTIBIOTIC RESISTANCE 
Every human being plays host to millions of bacteria, of many 
different species. I6 Many of the bacteria that live on and in the human 
body are beneficial to the host; some are even essential.I7 Of course, 
pathogenic bacteria (those capable of causing disease) also exist. IS 
Symptoms of a harmful bacterial infection may be due to the pres-
ence of microbial products such as toxins, or the host's immune re-
sponse to the bacteria.I9 The development and widespread availability 
of multiple classes of antibiotics in the latter half of the twentieth cen-
tury meant that we could cure many potentially life-threatening infec-
tions.20 
Unfortunately, the use of antibiotics, at both therapeutic and sub-
therapeutic levels, has led to the emergence of resistant bacteria that 
can survive in the presence of one or more classes of antibiotics.21 The 
use of antibiotics promotes resistance by killing off the bacteria that 
are most susceptible to the antibiotics. If the dosage is insufficient to 
kill off all the bacteria infecting the host, the bacteria that survive to 
propagate will be those that were most resistant to the effects of the 
antibiotics. 
16 Bacteria are single-celled prokaryotic microorganisms. "Prokaryotic" means that the 
cell contains a primitive nucleus where the DNA-containing region lacks a limiting mem-
brane. MCGRAW-HILL DICTIONARY OF SCIENTIFIC AND TECHNICAL TERMS 1588 (5th ed. 
1994). 
17 J. NICKLIN ET AL., INSTANT NOTES IN MICROBIOLOGY 156 (1999). 
18Id. at 156-57. 
19Id. at 157. 
20 Penicillin alone saved countless lives in World War II by preventing soldiers from dy-
ing as a result of bacterial infection following wounding. Harrison, Part I, supra note 4, at 
151. See also NICKLIN, supra note 17, at 179. Antibiotics operate in a number of different 
ways. Harrison, Part I, supra note 4, at 152. Some antibiotics, such as penicillins and cepha-
losporins, inhibit bacterial cell wall synthesis. Other antibiotics, such as aminoglycoside 
antibiotics and tetracycline, interfere with protein synthesis. A third mechanism, employed 
by sulfonamides and quinolones, inhibit synthesis of bacterial nucleic acid. NICKLIN, supra 
note 17, at 178. 
21 Levy, The Challenge, supra note 11, at 49-50. If the bacteria is resistant to more than 
one class of antibiotics, it is generally referred to as having multi-drug resistance. 
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Antibiotic resistance can take a number of different routes.22 For 
example, penicillin and chloramphenicol resistance generally occurs 
because the resistant bacteria are able to inactivate the antibiotics. 23 
Tetracycline resistance most commonly occurs when the bacteria are 
able to increase antibiotic efflux, transport of the antibiotic from the 
interior to the exterior of the cell.24 Additionally, bacteria may mutate 
so that the target sites which the antibiotics effect are altered.25 
Drug resistance is a particular problem in bacteria because resis-
tance is so readily transmitted from bacteria to bacteria, even to dif-
ferent bacteria species.26 In fact, noted microbiologist Stuart B. Levy 
has suggested that it makes sense to think of "the entire bacterial 
world ... as one huge multicellular organism in which the cells inter-
change their genes with ease."27 
There are a number of mechanisms by which drug resistance can 
spread among bacteria. While most of the essential genetic informa-
tion for each bacterium is contained within a single circular deoxyri-
bonucleic acid (DNA) strand,28 bacteria also carry extrachromosomal 
material in the form of plasm ids and transposons.29 Plasmids can 
transmit the characteristic of drug resistance30 between bacteria by 
conjugation, transformation, or transduction.31 Conjugation involves 
contact between two bacterial cells during which genetic material 
22 Random mutations may lead to resistance via any of a number of pathways, some of 
which are identified in the text of this article. Antibiotic use exerts a selective pressure so 
that the "mutant" strains have an evolutionary advantage, resulting in the creation of a 
dominant strain which exhibits the characteristic of resistance. 
23 NICKLIN, supra note 17, at 179. 
24 [d. 
25 Sulfonamide, methicillin, and trimethoprim resistance all occur because of such 
changes in the resistant bacteria. [d. 
26 One normally thinks of inherited characteristics passing only to successive genera-
tions of that particular organism. This is not the case for bacteria. 
27 Levy, The Challenge, supra note 11, at 48; see also Robert V. Miller, Bacterial Gene Swap-
ping in Nature, 278 SCIENTIFIC AMERICAN 66 (1998). 
28 Harrison, Part [, supra note 4, at 154. 
29 In the strictest sense of the word, transposons are not extrachromosomal since they 
are integrated into the chromosomal DNA. Plasmids are an extrachromosomal genetic 
element found among various strains of Escherichia coli and other bacteria. MCGRAW-HILL, 
supra note 16, at 1522. Transposons are a kind of translocatable genetic element which 
comprise large discrete segments of deoxyribonucleic acid capable of moving from one 
chromosomal site to another in the same organism or in a different organism. [d. at 2061. 
30 Plasmid-mediated resistance is of particular concern, not only because most bacte-
rial species carry plasmids, but because resistance mediated by plasm ids frequently results 
in multi-drug resistance. In addition, plasmids are easily transferred among bacterial 
strains and species. Harrison, Part l, supra note 4, at 154. 
31 NICKLIN, supra note 17, at 179. 
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passes from one cell to the other.32 Transformation consists of the 
transfer and incorporation of foreign DNA into a cell and subsequent 
recombination of part or all of that DNA into the cell's genome.33 
Transduction is the transfer of genetic material (which may be either 
chromosomal or plasmid DNA) between bacteria by bacteriophages.34 
The prevalence of plasmids in bacterial cells therefore means that it is 
likely that acquired characteristics will be shared with other bacteria. 
Transposons also facilitate the transfer of genes that enable the 
bacteria to become drug-resistant. When a bacterium dies, it typically 
releases its contents into the environment. Many intact bacteria con-
tain specialized transposons, termed integrons, "that are like flypaper 
in their propensity for capturing new genes. "35 The presence of these 
transposons further facilitates the transfer of resistance genes between 
bacteria. 
The speed with which bacteria propagate makes the problem of 
drug resistance particularly acute. Bacteria have a generation time 
that can be measured in minutes, and a single bacterium can easily 
produce more than a million progeny in less than a day.36 For exam-
ple, one Escherichia coli (E. colt) can produce more than a million 
progeny (about twenty generations) in seven hours. 37 Starting with a 
single drug-resistant bacterium, it does not take long to create mil-
lions of resistant bacteria first in the host and then in other hosts-as 
the bacteria itself spreads-or in the environment. 
The problem caused by the ready and rapid spread of drug-
resistance mechanisms among bacteria is further compounded by the 
fact that bacteria do not exist in isolated populations, but instead 
mingle among humans, animals and the environment.38 Resistance 
which develops in animal populations may soon emerge in human 
populations. Scientists have already discovered evidence of similar re 
32 Id. at 125-28. 
33 Id. at 144-45. 
34 Id. at 140-43. Bacteriophage, "normally called phage, are viruses that infect bacte-
ria. They are obligate intracellular parasites that are capable of existence as phage particles 
outside the bacteria cell but can only reproduce inside the cell." Id. at 127. 
35 Levy, The Challenge, supra note 11, at 49. 
36 Harrison, Part I, supra note 4, at 152. 
37 John W. Harrison & Timothy A. Svec, The Beginning of the End of the Antimotic Era? 
Part II. Proposed Solutions to Antimotic Abuse, 29(4) QUINTESSENCE INT'L 223, 223 (1998) 
[hereinafter Harrison, Part Il); see also Wolfgang Witte, Medical Consequences of Antimotic Use 
in Agriculture, 279 SCIENCE 959, 996-97 (1998). 
38 L. Tollefson et ai., Therapeutic Antimotics in AnimalFeeds and Antimotic Resistance, 16(2) 
REv. SCI. TECH. 709, 709-15 (1997). 
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sistance genes in bacteria of different genera inhabiting entirely dif-
ferent environments.!l9 Organisms originally present in an animal 
population have been found in humans who are in direct association 
with these animals or in contact with animal products.40 Once the re-
sistant bacteria is in the human population, it can easily spread fur-
ther to increasing numbers of human beings. One recent report 
characterizes the problem as follows: 
There are opportunities in the microbial environment 
for interconnected ecosystems to allow exchange of 
DNA, promoting the spread of resistance from one ge-
. nus to another. The combination of increased bacterial 
virulence and increased drug resistance creates a po-
tential for increased risk of morbidity and mortality for 
animals and humans that some have extrapolated to a 
catastrophic potential.41 
While it is impossible to trace specific bacterial infections among 
human populations back to the original source with 100% certainty, a 
growing body of scientific data points to the subtherapeutic dosing of 
livestock as a significant contributing factor in the spread of antibi-
otic-resistant organisms.42 Part III of this article will examine the cur-
rent research, but in order to place the evidence in context, it is criti-
cal to understand the role that antibiotics have come to play in 
American agriculture. 
II. THE USE OF ANTIBIOTICS IN AMERICAN AGRICULTURE 
At the current time, there are three primary uses of antibiotics in 
animal agriculture: therapeutic, prophylactic (to prevent potential 
infection), and growth promotion (with both of the latter two catego 
39 Stuart B. Levy, Antibiotic Use fur Growth Promotion in Animals: Ecologic and Public Health 
Consequences, 50(7)]. OF FOOD PROTECTION 616, 616-20 (1987) [hereinafter Levy, Antiboi-
toic Use]. Not incidentally, the spread of resistance in this manner demonstrates the com-
plexity of microbial spread ofresistance determinants. 
40 See generally A. H. Linton, Animal to Man Transmission of Enterobacteriaceae, 97 (3) R. 
Soc. HEALTH]. 115-18 (1977). 
41 NAT'L RESEARCH COUNCIL, supra note 5, at 70. 
42 S.D. Holmberg et aI., Drug-resistant Salmonella from Animals Fed Antimicrobials, 311 
NEW ENG.]. MED. 617, 621 (1984). "Transfer of antimicrobial-resistant bacteria from ani-
mals to human beings under natural conditions is thought to be frequent but impossible 
to determine accurately." See id. 
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ries being at sub therapeutic concentrations) .43 The use of antibiotics 
to ward off infections and to promote growth in livestock is not new. 
For more than 40 years many farmers have fed their animals a diet 
laced with small, subtherapeutic doses of antibiotics.44 
The discovery that antibiotics could be used for prevention of 
infection and growth promotion was serendipitous. Veterinarians be-
gan administering antibiotics to sick animals in an effort to determine 
whether the "miracle drugs" that were saving human lives could also 
help livestock.45 These experiments led to the discovery that feeding 
animals small doses of the drugs not only inhibited diseases but also 
enhanced growth.46 This discovery led in turn to an agricultural revo-
lution, with farmers-especially those in very large operations47-rely-
ing increasingly on sub therapeutic doses of antibiotics to keep their 
livestock healthy and to promote animal growth.48 
In the past three decades, agricultural use of antibiotics has in-
creased exponentially. One article has estimated that in the past thirty 
years, farmers have increased their use of penicillin-type antibiotics in 
43 NAT'L RESEARCH COUNCIL, supra note 5, at 19. 
44 STUART B. LEVY, THE ANTIBIOTIC PARADOX: How MIRACLE DRUGS ARE DESTROYING 
THE MIRACLE 138 (1992) [hereinafter LEVY, ANTIBIOTIC PARADOX]. 
45 Id. at 137-38. 
46 Id. at 138. 
47 "[F]armers with large operations were more likely than those with small farms to use 
antibiotics in feeds .... " George G. Khachatourians, Ph.D., Agricultural Use of Antibiotics 
and the Evolution and Transfer of Antibiotic-Resistant Bacteria, 159 CAN. MED. AsS'N. J. 1129 
(1988), athttp://www.cma.ca/cmaj/vol-159/issue-9/1129.htm. 
46 See generally, Barbara O'Brien, Comment, Animal Welfare Reform and the Magic Bullet: 
The Use and Abuse of Subtherapeutic Doses of Antibiotics in Livestock, 67 U. COLO. L. REv. 407 
(1996) (for a description of the conditions under which many farm animals are now 
raised). The author attributes the widespread use of antibiotics at subtherapeutic levels to 
changes in animal husbandry practices designed to maximize output. 
The farmer, having no rules or guidelines but industry standards by 
which to abide, will often treat animals like machines in order to 
maximize output and profit. Such an approach, however, requires an 
arsenal of drugs to ward off the inevitable infections and health prob-
lems that animals suffer when reared under stressful conditions. Anti-
biotics prevent the spread of infectious disease among herds kept in 
close confinement .... The use of sub therapeutic doses of antibiotics 
makes factory farm practices feasible. In one trade journal, a hog 
farmer remarked: 'One reason large confinement systems have worked 
so well is because of antibiotics. Without the antibiotics it would be 
hard to have these larger systems and crowd the pigs as we do in some 
cases.' 
Id. at 412-13 (citations omitted) . 
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farm animals by 600% and their use of tetracycline by 1500%.49 Re-
cent statistical research continues to show an increasing reliance on 
the routine use of antibiotics for pigs and cattle.50 Larger operations 
also continue to be more likely to use antibiotics,51 and many rely on 
additives for periods of time in excess of ninety days.52 
Part of the increase in antibiotic use is attributable to the declin-
ing effectiveness of the drugs as growth promoters. Over time, the 
amount of antibiotics needed to promote growth in farm animals has 
increased significantly. Some sources have suggested that "[r]oughly 
10 to 20 times the amount used four decades ago are required to pro-
duce the same level of growth in the 1990s. "511 Moreover, even at con-
centrations approaching therapeutic levels, "the benefits of growth 
promotion are less now than those reported several decades ago. "54 
The increasing use of antibiotics in agriculture has paralleled an 
astonishing growth in the use of antibiotics generally. In 1954 two mil-
lion pounds of antibiotics were produced in this country; today more 
than fifty million pounds of antibiotics are manufactured every year.55 
Only half of these antibiotics are consumed by human beings. Most of 
the remaining tens of millions of pounds annually are given to ani-
49 Alex Kirby, Why Farm Antibiotics are a Worry, (BBC NEWS, Oct. 8, 1999), avaiwble at 
http://news6.thdo.bbc.co.uk/hi/eng ... biotics/newsid%5f436000/436398.stm. 
50 USDA REPORT, supra note 3, at 21 (examining use of antibiotics in pigs between 
1990 and 1995). The same report suggests there has also been a recent decrease in reli-
ance on antibiotics in broiler operations in recent years. Id. at 27. The report attributes 
this decline to both the lack of new antibiotics approved for use in the poultry industry 
and "the implementation of multi-faceted preventative medicine programs(e.g. biosecu-
rity), increased efforts to reduce production costs, enhanced focus on residue avoidance, 
and rapid production of efficacious vaccines by manufacturers." Id. at 26-27. 
51 Id. at 24. Cattle operations with more than 1000 head of cattle were almost 3 times 
as likely to use antibiotics in food and water. Id. 
52 USDA REpORT, supra note 3, at 24 (42.1 % of large operations that use antibiotic ad-
ditives use them for periods of time in excess of 90 days, as compared with 32.2% of small 
operations that do so) . 
55 Harrison, Part l, supra note 4, at 157; accord Khachatourians, supra note 47. In the 
1950s the recommended levels of antibiotics for use as growth promoters were in the 5-10 
parts per million range. The 10 to 20 fold increase in recommended dosage is apparently 
not enough for all producers. An examination of 3,328 feeds in the U.S. National Swine 
Survey indicated that "up to 25% of the feeds contained antibiotics at concentrations 
higher than the recommended levels." C.E. Dewey et al., Association Between Off-whel Feed 
Additives and Farm Size, Veterinary Consultant Use, and Animal Agt1, 31 PREv. VET. MED. 133 
(1997). 
54 See gt1neraUy LEVY, ANTIBIOTIC PARADOX, supra note 44. 
55 Levy, The Challengt1, supra note 11, at 51. 
48 Environmental Affairs [Vol. 28:39 
mals.56 "While some of these antibiotics are used to treat infection, the 
bulk is mixed into animal feed at subtherapeutic levels.57 
Although farmers, veterinarians and drug companies protest the 
inadequacies of antibiotics available for use in livestock,58 a relatively 
wide variety of antibiotics have been approved for use as subtherapeu-
tic additives to animal feeds.59 Included in the list of antibiotics used 
as food additives in American agriculture are a number of drugs that 
are either themselves used as drug therapies for human patients or 
are closely related to such drugs. Amoxicillin, ampicillin, erythromy-
cin, neomycin, penicillin, and tetracycline are all used to treat human 
illness as well as being used in animal agriculture.6o 
A 1992 study examining the top ten drug-resistant microbes sug-
gests that a number of drugs fed to animals are now less effective in 
56 Some sources estimate that 40% of the total U.S. production of antibiotics is given 
to animals. [d. Other sources place the figure at closer to one half. NAT'L RESEARCH 
COUNCIL, supra note 5, at 25. Most of this amount, which clearly accounts for more than 20 
million pounds of antibiotics each year, is fed to animals in subtherapeutic amounts to 
promote growth or to prevent or limit potential infections. [d. (estimating that 90% of all 
antibiotics given to farm animals are used in subtherapeutic amounts). Accord Khacha-
tourians, supra note 47. 
57 [d. 
58 "As therapeutic options become less effective, drug companies and veterinarians 
have urged the approval of additional human-use antibiotics, such as fluoroquinolones, to 
treat animal diseases .... " Patricia B. Lieberman, Ph.D., & Margo G. Wootan, D.Se., Protect-
ing the Crown jewels of Medicine-A Strategic Plan to Preserve the Effectiveness of Antibiotics, Cen-
ter for Science in the Public Interest (1998), available at http:/www.espinet.org/re-
ports/ abiotic.htm. 
59 A December 1999 report of the United State Department of Agriculture lists the fol-
lowing antibiotics and sulfonamides for growth promotion and feed efficiency, therapeutic 
purposes or both in dairy and beef cattle: amoxicillin, ampicillin, bacitracin, ceftiofur, 
chlortetracycline, dihydrostreptomycin, erythromycin, furamazone, gentramycin, lacalo-
cid, monensin, neomycin, oxytetracycline, penicillin, streptomycin, tetracycline, tilmicosin, 
tylosin, sulfabromomethazine, sulfachloropyridazine, sulfaethoxypyridazine, sulfaethazine, 
and sulfamethoxine. USDA REpORT, supra note 3, at 19. The following antibiotics are ap-
proved for use in hogs: amoxicillin, ampicillin, apramycin, bacitracin, chlortetracycline, 
efrotomycin, lincomycin, neomycin, oleandomycin, oxytetracycline, penicillin, spectino-
mycin, streptomycin, tetracycline, tiamulin, tylosin, and virginiamycin. [d. Various sul-
fonamides have also been approved for use in hogs. [d. Fewer antibiotics have been ap-
proved for use in sheep. They include chlortetracycline, erythromycin, neomycin, 
oxytetracycline, penicillin, and penicillin/streptomycin. [d. The following antibiotics have 
been approved by the Food and Drug Administration (FDA) for use in chickens and tur-
keys: bambermycin, bacitracin, chlortetracycline, erythromycin, gentramycin, neomycin, 
novobiocin, oleandomycin, oxytetracycline, penicillin, roxarsone, spectinomycin, strepto-
mycin, tetracycline, tylosin, virginiamycin and fluoroquinolones. [d. Various sulfonamides 
have also been approved for use in poultry. USDA REpORT, supra note 3, at 19-20. 
60 Lieberman, supra note 58. Another antibiotic approved for use with livestock, ty-
losin, is closely related to the family of drugs that includes erythromycin. [d. 
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treating a wide variety of human ailments.61 Enterobacteriaceae, which 
cause bacteremia, pneumonia, and urinary tract and surgical wound 
infections, may be resistant to aminoglycosides (such as vancomycin), 
beta-Iactam antibiotics (such as penicillin), chloramphenicol and tri-
methoprim.62 Enterococcus, which is implicated in all of the foregoing 
diseases except pneumonia, may be resistant to aminoglycosides, beta-
lactams, and erythromycin.63 Haemophisus injluenzae, which causes 
epiglottitis, meningitis, otitis media, pneumonia and sinusitis, may be 
resistant to beta-Iactams, chloramphenicol, tetracycline and trimetho-
prim.64 Mycobacterium tuberculosis, which causes tuberculosis, may be 
resistant to aminoglycosides, ethambutol, isoniazid, pyrazinamide and 
rifampin.65 Neisseria gonorrhoeae, which causes gonorrhea, may be resis-
tant to beta-Iactams, spectinomycin, and tetracycline.66 Other mi-
crobes listed as causing serious diseases may be resistant to chloro-
quine, ciprofioxacin, sulfonamides, and/or clindamycin as well as the 
drugs listed above.67 
In 1969, a report commissioned by the English Parliament on the 
use of antibiotics in animal husbandry and veterinary medicine rec-
ommended a ban on the subtherapeutic use of antibiotics in food 
producing animals.68 This report, chaired by Professor M.M. Swann, 
widely known as the "Swann Report," concluded that "the administra-
tion of antibiotics to farm livestock, particularly at sub-therapeutic 
levels, poses certain hazards to human and animal health. "69 The final 
recommendation of the Swann Report was that only antibiotics that 
"have little or no application as therapeutic agents in man or animals 
and will not impair the efficacy of a prescribed therapeutic drug or 
drugs through the development of resistant strains" should be used 
for growth promotion.70 The report specifically identified chlortetra-
61 Expluring New Strategies to Fight Drug-Resistant Microbes, 257 SCIENCE 1036, 1036 (Aug. 





66 Expluring New Strategies, supra note 61, at 1036. 
67Id. 
68 See HOUSE OF LORDS, SCIENCE AND TECHNOLOGy-SEVENTH REpORT (Mar. 17, 
1998), available at http://www.parliament.the-stationery-office ... 199798/Idselect/ 
Idsctech/ 081vii/st0701.htm [hereinafter HOUSE OF LORDS]; REpORT OF THE COMPTROL-
LER GENERAL OF THE UNITED STATES, NEED TO ESTABLISH SAFETY AND EFFECTIVENESS OF 
ANTIBIOTICS USED IN ANIMAL FEEDS 10 (1977) [hereinafter COMPTROLLER'S REpORT]. 
69 HOUSE OF LoRDS, supra note 68. 
7°Id. 
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cycline, oxytetracycline, penicillin, tylosin (which is related to eryth-
romycin) and the sulphonamides as unsuitable for use as growth 
promoters. 71 
Although the Swann Report was relatively influential in the 
United Kingdom, its recommendations have never been adopted in 
the United States.72 At one point, in the 1970s, the FDA proposed 
rules which would have prohibited the use of penicillin and tetracy-
clines as food additives for disease prevention and growth promo-
tion.73 Because of political opposition, however, the proposed rule was 
never promulgated.74 Instead, the United States continues to study 
the issue while new drugs are added to the list of antibiotics approved 
for use in agriculture. 
Most recently, in 1995, the FDA approved the use of 
fluoroquinolones in farm animals.75 The FDA approved this use "de-
spite vigorous opposition by the CDC and the Infectious Disease Soci-
ety of America (IDSA). "76 To address some of their concerns, the FDA 
restricted the use of this class of antibiotics to short-term use in lim-
ited situations, but the permitted uses still include the dosing of en-
tire poultry flocks through their drinking water.77 The potential prob-
lems posed by fluoroquinolone resistance are significant because 
71 Id. 
72 For comparison purposes, England implemented the Swann Report recommenda-
tions in. March 1971 by issuing the Therapeutic Substances Regulation of 1971 which, 
among other things, restricted the availability of penicillin, chlortetracycline, oxytetracy-
cline, tylosin, nitrofurans and most sulfonamides. COMPTROLLER'S REpORT, supra note 68, 
at 10. 
73 See generally COMPTROLLER'S REpORT, supra note 68, and Lieberman, supra note 58. 
The FDA published rules in the April 20, 1973 Federal Register which stated the agency's 
intention to withdraw approval for the subtherapeutic use of antibiotics in animal feeds 
within two years "unless data were submitted by drug sponsors to establish conclusively ... 
their safety to humans and animals and effectiveness for their intended purposes." COMP-
TROLLER'S REpORT, supra note 68, at 10-11. 
74 The Comptroller's Report noted that despite the original promulgation of rules 
which would have withdrawn approval for the subtherapeutic use of antibiotics in 1975, 
the FDA "permitted the continued use of the products" despite the fact that "a number of 
the antibiotics currently marketed for subtherapeutic use in animals feeds, including peni-
cillin, tetracyclines, and sulfaquinoxaline, have been shown to either create a hazard to 
human or animal health or have not been shown to be effective for some of their disease 
prevention uses." Id. at 34. 
75 Lieberman, supra note 58. 
76Id. 
77 Id. Two years after this approval, the Minnesota State Department of Health re-
ported a significant increase in fluoroquinolone resistance in bacteria isolated from poul-
try and human beings. The CDC also reported that 13% of human Campylobacter isolates 
have become fluoroquinolone resistant. Id. 
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fluoroquinolones are the primary treatment for resistant stains of 
Salmonella typhimurium in human beings.78 Fluoroquinolones are criti-
cally important in treating several other bacteria as well.79 
III. EVIDENCE CONCERNING THE EFFECT OF SUB THERAPEUTIC DOSING 
AND ITS RISK TO HUMAN HEALTH 
Members of the scientific community and the general public 
share a growing concern about the decrease in effectiveness and/or 
usefulness of antibiotics. The question remains, however, whether the 
use of antibiotics at subtherapeutic levels in farm animals has con-
tributed to the spread of antibiotic-resistant bacteria in a manner 
which poses a significant risk to human health.80 Many health organi-
zations, including the World Health Organization and the Institute of 
Medicine, regard antibiotic resistance as "a documented major health 
threat around the world. "81 Despite protests from the agricultural 
community and drug companies, there is a general consensus among 
scientists that subtherapeutic doses of antibiotics used in animal feed 
favors the selection of antibiotic-resistant bacteria.82 
Despite the growing concern in the scientific community, very 
little has been written about this subject in legal literature. One recent 
law review article complaining about the use and abuse of sub-
therapeutic doses of antibiotics in livestock feed focused primarily on 
the ethics of animal husbandry in the United States.83 Two other stu-
dent articles which purport to address the "epidemic of antibiotic re-
sistance" target only physician-prescribing practices, completely ignor-
78 Id. (noting that 32% of Salmonella typhimurium cases in the U.S. (approximately 3,000 
cases confirmed with cultures) are resistant to ampicillin, chloramphenicol, streptomycin, 
sulphonamides and tetracyclines (all antibiotics that are or were commonly used in ani-
mals)). In addition, fluoroquinolones are important in treating humans for urinary tract 
infections, sexually transmitted diseases, invasive CamfrYlobacter infections, respiratory infec-
tions, infections in patients with cystic fibrosis, and many other antibiotic-resistant diseases. 
Lieberman, supra note 58. 
79Id. 
80 NAT'L RESEARCH COUNCIL, supra note 5, at 70. 
81 WORLD HEALTH ORG., THE MEDICAL IMPACT OF ANTIMICROBIAL USE IN FOOD ANI-
MALS, REpORT OF A WHO MEETING. Berlin, Germany (WHO Doc. WHO/EMC/ZOO/97.4 
(1997). 
82 NAT'L RESEARCH COUNCIL, supra note 5, at 150. This source also notes a number of 
other factors, including: crowded confinement of numerous animals with similar disease 
susceptibilities, poor animal hygiene, and other practices which also contribute to the 
selection of antibiotic-resistant bacteria. Id. 
83 See generally O'Brien, supra note 48. While this article does address the issue of anti-
biotic resistance, the author mainly addresses the conditions in which animals in the 
United States are currently raised. 
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ing the role of antibiotics in agriculture as a contributing factor in the 
spread of antibiotic resistance in humans.84 
Even in the scientific community, there is disagreement as to 
whether there is sufficient documentation linking subtherapeutic dos-
ing of livestock with the spread of antibiotic-resistant bacteria in hu-
man populations. A recent multi-disciplinary report concluded that 
"the basic answer to the question of human health consequences of 
antibiotic drug use in food animals is still not known for certain. "85 
Despite agreement that antibiotic use "increases the risk of emer-
gence of microorganisms that are resistant to specific, and perhaps 
other, antibiotics," and acknowledgement that "[a] link can be dem-
onstrated between the use of antibiotics in food animals, the devel-
opment of resistant microorganisms in those animals, and the zoo-
notic86 spread of pathogens to humans," this recent multi-disciplinary 
report ultimately concluded that "the use of drugs in the food-animal 
production industry is not without some problems and concerns, but 
... does not appear to constitute an immediate public health concern 
"87 
Given this background, it seems essential to consider the cur-
rently available scientific data examining whether and how the prac-
tice of feeding farm animals sub therapeutic doses of antibiotics con-
tributes to the spread of antibiotic-resistant bacteria in human beings. 
A wide variety of studies have been performed which shed light on 
the link between antibiotic use in animal agriculture and drug-
resistant bacterial infections in the human population. Most of the 
data comes not from controlled, laboratory experiments, but from 
the collection and analysis of data from animal and human case stud-
ies. These studies provide substantial evidence that the subtherapeutic 
use of antibiotics in livestock promotes the subsequent spread of 
drug-resistant bacteria which poses a risk to human health. 
Some of these studies have focused on the question of how the 
subtherapeutic use of a particular antibiotic as a food additive for live-
84 Markow, supra note 9; Misocky, supra note 7. 
85 NAT'L RESEARCH COUNCIL, supra note 5, at 15. This report was put together by the 
National Research Council's Committee on Drug Use in Food Animals. Id. at 2. This 
committee consisted of a number of academicians and health care professionals, two con-
sumer group representatives, a farmer and a director of a corporate poultry business unit. 
Id. at 235-38. 
86 A "zoonotic" disease is one that is "biologically adapted to and normally found in 
lower animals but which under some conditions also infects humans." MCGRAW-HILL, 
supra note 16, at 2193 (defining zoonoses). 
87 NAT'L RESEARCH COUNCIL, supra note 5, at 7-9. 
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stock affects drug resistance in bacteria in the animals and those who 
come into contact with those animals. One of the most convincing 
reports involved an analysis of the effects of the growth promoter 
nourseothricin in the former East Germany.88 Farmers used this anti-
biotic in pig feed from 1983 to 1990, replacing the similar use of oxy-
tetracycline.89 Enterobacteriaceae isolated from both humans and ani-
mals in 1983 showed little resistance to nourseothricin, but by 1985 
transposon-encoded resistant E. coli were isolated from pigs and meat 
products.90 By 1990, the resistant bacteria had also spread to the 
farmers, their families, and people living in surrounding areas.91 The 
same study also noted that the resistant transposon had further spread 
among several other species of bacteria including Shigella, a human 
pathogen.92 Other researchers have reported similar results.93 
This research is particularly significant because the same drugs 
are often used in both farm animals and humans, making it difficult 
to accurately trace the spread of resistance determinants in bacteria 
found in animals to those found in humans. Nourseothricin, however, 
was used for growth promotion in pigs but was not given directly to 
humans. Nonetheless, within a few years after its introduction into pig 
feed, plasmid-borne resistance to nourseothricin was observed not 
only in E. coli from pigs fed subtherapeutic doses of nourseothricin, 
but also in similar bacteria from employees at the pig farms, their 
family members, and members of the surrounding community.94 In 
this instance, the presence of resistant bacteria in the human subjects 
was not attributable to the direct use or misuse of the antibiotic in the 
human population since the drug in question was fed only to the pigs. 
A variety of case studies have also been performed in connection 
with salmonella outbreaks.95 In each of the following instances, the 
researchers attempted to trace human infections back to their origi-
nal source. One such study investigated the origin of drug-resistant 
salmonella infections in fifty-two outbreaks originally examined by the 
88 Witte, supra note 37, at 996-97. 
89 Id. at 996. 
90 Id. 
91Id. 
92 H. Tschiipe, 15 FEMS MICROBIOLOGY LETTERS 23 (1994), cited in Witte, supra note 
37, at 996. 
95 See Ruth Hummel et al., spread of Plasmid-mediated Nourseothricin Resistance Due to An-
tibiotic Use in Animal Husbandry, 26]. BASIC MICROBIOLOGY 461-66 (1986). 
94 Id. 
95 E.g., Scott D. Holmberg et al., Animal-to-Man Transmission of Antimicrobial-Resistant 
Salmonella: Investigations of u.s. Outllreaks, 1971-1983, at 225 SCIENCE 833, 833-35 (1984). 
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CDC.96 Of the fifty-two incidents investigated, thirty-eight outbreaks 
were associated with identifiable sources. Food animals were found to 
be the source of eleven of the sixteen resistant outbreak strains and 
six of the thirteen sensitive strains.97 This research is particularly 
alarming because the case fatality rate was significantly higher for pa-
tients infected with antimicrobial-resistant salmonella (4.2%) than for 
those with antimicrobial-sensitive infections (0.2%) .98 
Another report examined case histories of eighteen people in-
fected with resistant Salmonella newport in 1983.99 The researchers in 
this case ascertained that this particular strain of bacteria, character-
ized by a 38-kilobase plasmid, was resistant to ampicillin, carbenicillin, 
and tetracycline. loo The researchers compared the plasmids isolated 
from human and animal sources over a period of eighteen months. 101 
Examination of meat distribution records indicated that the humans 
had been infected by eating hamburger originating from South Da-
kota beef cattle which had been fed subtherapeutic doses of chlortet-
racycline, a growth promoter.102 The researchers acknowledged 
difficulties in studying the complex sequence of events that begin with 
the selection of drug-resistant organisms in animals fed subtherapeu-
tic quantities of antimicrobials and end with clinically significant in-
fections in human beings; still, they concluded that "antimicrobial-
resistant organisms of animal origin cause serious human illness, and 
[their study] emphasizes the need for more prudent use of antimi-
crobials in both human beings and animals. "103 
Another case study involved a 1983 outbreak of salmonella poi-
soning that resulted from ingestion of raw milk contaminated with 
multi-resistant Salmonella typhimurium.l04 In the study, a seventy-two 
year-old woman did not respond to treatment and died from salmo-
nella enteridis and sepsis.105 Experimental results showed that isolates 
of Salmonella typhimurium from this patient, from other ill persons, and 
96 Id. at 833. 
97 Id. Antibiotic susceptibility was not determined in the remaining instances. Id. at 
833-34. 
98 Id. at 834. 
99 Holmberg et ai., supra note 43, at 617. 
100 Id. 
101Id. 
102Id. at 619-20. 
103Id. at 617. 
104 Carol O. Tacket et ai., An Outbreak of Multiple-Drug-Resistant Salmonella Enteritis 
from Raw Milk, 253 JAMA 2058, 2058-60 (1985). 
105 Id. at 2058. 
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from raw milk from a particular dairy were resistant to several antibi-
otics including streptomycin, sulfonamide, chloramphenicol, kana-
mycin sulfate, and tetracycline.I06 The multi-drug resistance in these 
isolates was traced back to the raw milk that the affected individuals 
had consumed.107 The authors of the study concluded that "[t]his 
outbreak demonstrates the ability of drug-resistant salmonella to 
spread from the animal to the human reservoir and, III a suitable 
host, produce a fatal infection. "108 
Researchers also investigated a five-fold increase in Salmonella 
newport cases in California in 1985.109 Results of genetic analysis 
showed that nearly 90% of the Salmonella newport isolates in the survey 
population had an unusual pattern of drug-resistance, including resis-
tance to chloramphenicol.110 This resistance was traced to a single 
plasmid isolated from hamburger products, slaughterhouses which 
were the source of the infected meat, a limited number of dairies that 
sent cows for slaughter, and sick dairy cows.111 Isolation of salmonella 
with the unusual resistance to chloramphenicol correlated to the use 
of chloramphenicol at the dairies where cows had tested positive for 
Salmonella newport.112 The authors concluded that "food animals are a 
major source of antimicrobial-resistant salmonella infections in hu-
mans and that these infections are associated with antimicrobial use 
on farms. "113 
Researchers also traced an epidemic outbreak of Salmonella hei-
delberg in a hospital nursery to calves on a dairy farm where the 
mother of the primary infant patient lived.114 Salmonella isolates from 
all identified cases were resistant to several antimicrobials, including 
chloramphenicol and tetracycline,115 suggesting that the infections 
developed from a common source. 
106 [d. at 2058-59. 
107 [d. at 2058. 
108 [d. "This outbreak demonstrates the importance of animals as a source of antimi-
crobial-resistant Salmonella .... [O]ther outbreaks have clearly demonstrated the spread 
of resistant organisms from an animal reservoir to humans." [d. at 2060. 
109 John S. Spika et aI., Chlmamphenicol-Resistant Salmonella Newport Traced Through 
Hamburger to Dairy Farms: A Major Persisting Source of Human Salmonellosis in California, 316 
NEW ENG.]' MED. 565, 565 (1987). 
110 [d. at 565. 
111 [d. at 566-68. 
112 [d. at 568. 
113 [d. at 565. 
114 Robert W. Lyons et aI., An Epidemic of Resistant Salmonella in a Nursery-Animal-to-
Human spread, 243 JAMA 546, 546 (1980). 
115 [d. at 546. 
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Similar investigations have also focused on other kinds of bacte-
ria.1I6 In one case, researchers investigated the presence of Enterococ-
cus faecium strains resistant to glycopeptides (such as vancomycin) in a 
hospital setting.1l7 The resistant bacteria in this study were identified 
in chicken carcasses from a hospital's kitchen.ns Bacteria with the 
same resistance patterns were also identified in animals from both a 
pig farm and a poultry farm where avoparcin (another glycopeptide) 
was used as a food additive.1I9 The researchers concluded that it was 
"probable" that the bacteria from the farm animals had been trans-
mitted to the hospitaI.l20 "Obviously as shown here animal farms with 
ergo tropic use of avoparcin are an important reservoir for vanA-
carrying enterococci. Via food contamination, these bacteria can also 
be disseminated to humans. "121 
Not all research on antibiotic resistance has involved the study of 
actual case histories. For example, other research has focused on the 
mechanisms by which resistance might be transferred between ani-
mals and humans. Researchers involved in these efforts have at-
tempted to identify evidence which would make the transfer of resis-
tant bacteria between animal species and human beings plausible. 
Regardless of a study's focus, salmonella remains a favorite sub-
ject of investigators, possibly because of its serious potential impact on 
human health. One study concluded that plasm ids found in out-
breaks of Salmonella typhimurium were similar in both animals and 
humans.122 Researchers tested isolates of salmonella from reference 
laboratories in the United States to determine their susceptibility to 
antibiotics, and also extracted plasmids from isolates resistant to dif-
116 E.g., Janice Bates et al., Farm Animals as a Putative Reservoir for Vancomycin-Resistant 
Enterococcal Infection in Man, 34]. ANTIMICROBIAL CHEMOTHERAPY 507, 507-14 (1994) 
(demonstrating farm animals are a source of vancomycin-resistant enterococct). 
117 I. Klare et ai., vanA-Mediated High-Level Glycopeptide Resistance in Enterococcus fae-
cium from Animal Husbandry, 125 FEMS MICROBIOLOGY LETTERS 165, 165 (1995) (pub-
lished erratum appears in 127 FEMS MICROBIOLOGY LETTERS 273 (1995». This is particu-
larly worrisome because the vanA gene confers a high level of resistance to vancomycin, 
often the antibiotic of last resort in human beings. See Bates, supra note 116, at 507-14. For 
a further discussion of the importance of vancomycin resistance, see infra notes 125-128 
and accompanying text. 
liB Id. at 165. 
119 Klare, supra note 117, at 165. When researchers tested chickens from a farm where 
avoparcin was not used, no glycopeptide-resistant enterococci were isolated. Id. 
120 Id. at 165-66. 
121 Id. at 170. 
122 T.F. O'Brien et ai., Molecular Epidemiology of Antibiotic Resistance in Salmonella from 
Animals and Human Beings in the United States, 307 NEW ENG.]. MED. 1, 1 (1982). 
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ferent combinations of antibiotics.123 These researchers used restric-
tion endonuclease digestion to demonstrate that plasmid molecules 
from animal and human isolates were frequently identical or ex-
tremely similar.124 These findings suggest that resistance plasmids may 
be widely shared between animal and human bacteria.125 
Another research team recently demonstrated that the molecular 
characteristics, as determined by pulsed-field gel electrophoresis 
(PFGE),126 of a ceftriaxone-resistant strain of Salmonella enterica sero-
type typhimirium isolated from a child were indistinguishable from 
one isolated from cattle.127 The isolates were both resistant to thirteen 
antimicrobial drugs.l28 "This study provides additional evidence that 
antibiotic-resistant strains of salmonella in the United States evolve 
primarily in livestock. "129 
Another favorite research subject130 is vancomycin-resistant bacte-
ria, particularly Enterococcus jaecalis (E. jaecalis). The spread of vanco-
mycin-resistant bacteria is significant for human health officials and 
other observers because vancomycin is the antibiotic of last resort for 




126 Pulsed-field gel electrophoresis is considered to be the most sophisticated method 
of showing that isolates from animals and humans are equivalent. See]. Bates, Epidemiology 
of Vancomycin-Resistant Enterocci in the Community and the Relevance of Farm Animals to Human 
Infection, 37]. HOSPITAL INFECTION 89, 96 (1997). 
127 Paul D. Fey et aI., Ceftriaxone-Resistant Salmonella Infection Acquired fly a Child from Cat-
tle, 342 NEW ENG.]. MED. 1242, 1242 (2000). 
128 [d. 
129 [d. 
130 Salmonella and Enterococcus faecalis are not the only strains of bacteria which have 
been studied or identified in both animal and human populations. See, e.g., Lawrence]. 
Abraham et aI., Worldwide Distribution of the Conjugative Clostridium perfringens Tetracycline 
Resistance Plasmid, pCW3, 14 PLASMID 37 (1985) (identifYing identical conjugative R-
plasmids from C. perfringens strains from human, animal, and environmental sources in five 
countries and concluding that C. perfringens strains in humans and animals throughout the 
world have overlapping gene pools). 
131 This topic is addressed thoroughly in a recent biomedical essay by C.P. Hunt of the 
British Department of Clinical Microbiology. See C.P. Hunt, The Emergence of Enterococci as 
a Cause of Nosocomial Infection, 55 BRITISH]' BIOMEDICAL SCI. 149-56 (1998). Hunt con-
tends that "[tlhe possibility that vancomycin-resistant strains of enterococci are entering the 
community via the food chain indicates the need for greater control of the use of glyco-
peptide antibiotics in animal feed." Id. at 149. Enterococci readily transfer antibiotic resis-
tance between strains and, in addition, enterococcal plasm ids frequently encode multiple-
resistance determinants which simultaneously allows the transfer of multiple antibiotic 
resistance. Id. at 151. Of particular concern is the potential for the spread of vancomycin 
resistance. Experiments have demonstrated that the vanA gene can be found in corynebacte-
58 Environmental Affairs [Vol. 28:39 
aureus) (a major cause of hospital-acquired infections) can be fatal, 
and "[w]orldwide, many strains of S. aureus are already resistant to all 
antibiotics except vancomycin. "132 Health officials have expressed 
concern that the spread of vancomycin-resistant E. faecalis ''will soon 
deliver strong vancomycin resistance to those S. aureus strains, making 
them incurable. "133 
Vancomycin is a glycopeptide used to treat human infections; 
avoparcin, a glycopeptide which shows cross-resistance to vancomycin, 
is or was fed to livestock as a growth promoter worldwide, with the 
notable exceptions of Canada and the U.S.134 The use of avoparcin as 
a growth promoter added to animal feeds was particularly extensive in 
countries in the European Community.135 Thus, studies of vancomy-
cin-resistant bacteria provide a basis for concern about the spread of 
cross-resistance of at least some antibiotics used as additives in live-
stock feeds. 136 
One study of vancomycin-resistant enterococci (VRE) examined 
samples of vancomycin-resistant Enterococcus faecium (E. faecium) from 
clinical sources, including sixty-two isolates from non-human sources, 
thirty-five isolates from raw sewage, twenty-two from farm animals, and 
five from uncooked chickens.137 All strains possessed the vanA gene 
which confers a high level of resistance to vancomycin.138 Further 
characterization of forty-two of these isolates resulted in fourteen 
clearly distinguishable types, two of which were ribotyping patterns 
rium, arcanobacterium, and lactobacillus emphasizing the potential for spread of vancomycin 
resistance. Id. Vancomycin-resistant strains of E. Faecium have been found both in healthy 
animals and in animal products. These findings suggest that vancomycin-resistant bacteria 
may be entering the community via the food chain. Id. at 153. The author concludes that it 
is quite possible that avoparcin, a glycopeptide with cross-resistance to vancomycin which 
has been used as a growth promoter in animal feeds since the mid 1970s, contributes to 
the seriousness of the problem. Id. 
132 Levy, The Challenge, supra note 11, at 46. 
133 Id. Laboratory experiments have demonstrated that, under conditions similar to 
those found in the environment, high levels of vancomycin resistance can be transferred 
via conjugation from E. faecalis to S. aureus. E.g., W.C. Noble et aI., Co-Transfer of Vancomycin 
and Other Resistance Genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus, 72 (2) 
FEMS MICROBIOLOGY LETTERS 195, 197 (1992). 
134 Bates, supra note 126, at 93. 
uS1d. 
136 Id. at 99. Bates also cites a study which suggests that the emergence of quinolone-
resistance infections in humans is linked to the use of enrofloxacin (a fluroquinolone) as a 
growth promoter in poultry. H.P. Endtz et aI., Fluroquinolone Resistance in Campylobacter 
spp. Isolated from Human Stools and Poultry Products, 335 LANCET 787 (1990), cited in Bates, 
supra note 126, at 93. 
137 Bates, supra note 116, at 507. 
138 Id. 
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found in both animal and human sources.1!19 These results indicate 
that animals may likely serve as a source of VRE which may allow the 
bacteria to enter humans through the food chain.140 
Another researcher investigated the occurrence and spread of 
non-nosocomial highlevel glycopeptide-resistant, vanA-positive E. fae-
cium strains.141 Highly resistant E. faecium were isolated from commer-
cially available frozen poultry.142 In addition, glycopeptide-resistant E. 
faecium (vanA type) were detected in five of thirteen samples of raw 
meat from pigs originating from thirteen different butchers' ShopS.14!1 
In addition to the animal sources, twelve of 100 non-hospitalized hu-
mans from nearby rural areas demonstrated detectable quantities of 
vanA type E. faecium strains.l44 This research suggests a wide dissemi-
nation of vancomycin resistance, primarily in animal populations but 
also at significant levels in human populations. 
Experiments from Germany using PFGE showed that a strain of 
VRE from a human and an isolate from minced pork were indistin-
guishable.l45 Short reports from the Netherlands found indistinguish-
able isolates (again using PFGE) from a turkey and a turkey farmer. l46 
These studies provide substantial evidence that resistant bacteria are 
present in both animal and human populations, and that the mecha-
nisms for resistance are often indistinguishable. 
Other studies have focused on the related question of whether 
the resulting antibiotic resistance is associated with sub therapeutic 
dosing of farm animals with antibiotics. For example, in 1995, the 
Danish Veterinary Laboratory completed a detailed comparison of 
farms using and not using avoparcin, and concluded that VRE is fifty-
five times more likely to be detected if the farm animals in question 
159 Id. at 511. 
140 Id. at 507. 
141 I. Klare et aI., Enterococcus faecium Strains with vanA-Mediated High-Level Glycopep-
tide Resistance Isolated frum Animal Foodstuffs and Fecal Sampks of Humans in the Community, 1 
MICROBIAL DRUG RESISTANCE 265, 265 (1995). 
142 Id. No glycopeptide-resistant enterococci could be detected in samples of chickens 
where the feed history did not include avoparcin. Id. 
143Id. 
144 [d. 
145Bates, supra note 126, at 96. 
146A. Van den Bogaard et aI., Prevalence of Resistance of Fecal Bacteria in Turkeys, Turkey 
Farmers and Turkey Slaughterers (Abstract) E27 36TH INTERSCIENCE CONFERENCE ON ANTIMI-
CROBIALAGENTS AND CHEMOTHERAPY 86 (1996), cited in Bates, supra note 126, at 96. 
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were fed avoparcin.147 In five out of eight chicken farms using avopar-
cin, resistant bacteria were isolated.l48 At the same time, of the six 
conventional farms where avoparcin was not used, none tested posi-
tive for the resistant strains.149 
Another laboratory experiment examined the plasmid contents 
and antibiotic susceptibilities of streptococci isolated from pigs fed 
tylosin.150 This research showed an increased risk for the spread of 
resistance as a consequence of tylosin feeding.151 Data showed the ad-
dition of tylosin to the feed selected for multiple antibiotic resis-
tance.152 More importantly, a strong sequence homology was estab-
lished between resistance genes in isolates from humans and those 
from farm animals.153 
Yet another survey looked at the question of whether food prod-
ucts could act as the vector through which antibiotic-resistant bacteria 
might travel. An investigation of vancomycin-resistant bacteria in a 
vegetarian and a non-vegetarian nursing home in the Netherlands 
revealed that of the forty-two persons in the vegetarian nursing home, 
although twenty-three tested positive for the bacteria Enterococcus fae-
cium, none tested positive for the resistant variety.154 In comparison, of 
the sixty-two patients in the non-vegetarian nursing home thirty-two 
patients tested positive for Enterococcus faecium and six residents tested 
positive for strains resistant to vancomycin.l55 
In addition to the more limited data suggested by these kinds of 
experiments or case studies, some researchers have attempted to 
demonstrate the entire process by which subtherapeutic dosing of 
animals promotes the growth of drug-resistant bacteria and the 
spread of such microorganisms from animal to man. One such study 
147 F.M. Aarestrup, Occurrence of Glycopeptide Resistance Among Enterococcus faecium Iso-
lates from Conventional and Ecological Poultry Farms, 1 MICROBIAL DRUG RESISTANCE 255, 
255-57 (1995). 
148 Id. 
149 Id. at 255-56. 
ISO PJ. Christie & G.M. Dunny, Antibiotic Selection Pressure Resulting in Multiple Antibiotic 
Resistance and Localization of Resistance Determinants to Conjugative Plasmids in Streptococci, 
149]. INFECTIOUS DISEASES 74, 74 (1984). 
151 Id. at 74. 
152 Id. at 77. 'These analyses strongly suggest that the introduction of a macrolide anti-
biotic into the feed of livestock creates a pressure for the selection of a multiple drug-re-
sistant bacteria." Id. 
153 Id. at 74. 
154 Henrik C. Wegener et aI., Use of Antimicrobial Gruwth Promoters in Food Animals and 
Enterococcus faecium Resistance to Therapeutic Antimicrobial Drugs in Europe, 5(3) EMERGING 
INFECTIOUS DISEASES 329, 331 (1999). 
155Id. 
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was conducted by Stuart B. Levy and associates in the late 1980s.I56 His 
experiments started with a group of young chickens, all of which were 
progeny of hens that had not been exposed to any antibiotic for more 
than a decade.157 The chickens were divided into two groups; one 
group was fed subtherapeutic doses of oxytetracycline while the other 
group's feed was free of antibiotics. Inspection of the fecal material 
from the two groups revealed dramatic changes and differences over 
time. Chickens fed subtherapeutic doses of tetracycline began excret-
ing increasing numbers of tetracycline-resistant organisms in under 
two days, and in short order more than 90% of the excreted coliforms 
from this group were resistant.l58 The bacteria isolated from the con-
trol group remained mainly sensitive to tetracycline.159 In addition, 
the tetracycline-fed chickens were excreting multi-drug-resistant or-
ganisms within three months while the control group's excrement did 
not contain multiply-resistant flora.l60 
Perhaps the most worrisome data reported by Levy was that not 
only the chickens were affected. Humans living on the farm where the 
chickens were being given subtherapeutic doses of the antibiotics 
were also affected.161 Within six months of the introduction of the tet-
racycline-supplemented feed, individuals on the farm began to ex-
crete tetracycline-resistant and multiply-resistant organisms. Samples 
from a group of neighbors showed no corresponding changes.162 
Further experiments to determine the effects of the removal of 
tetracycline from the chicken feed showed that removal, even with 
multiple cleaning of the cages, did not significantly reduce the levels 
of tetracycline-resistant organisms, even though no tetracycline was 
detected in the samples.163 The chickens had to be removed to a new 
environment before non-resistant bacteria began to reappear in the 
chickens. l64 
Levy and his co-workers also studied the spread of this resistance. 
They introduced a marked plasmid (bearing a temperature sensitive 
chloramphenicol acetyltransferase gene) into Escherichia coli (E. 
156 Levy, Antibiotic Use, supra note 39, at 616-17. 
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cob) .165 Chickens were then inoculated with this bacteria and fed tet-
racycline to establish the marked strains. The chickens were then di-
vided into two groups, (each group housed separately), with one 
group being fed tetracycline-supplemented feed and the other fed 
normal feed.166 The researchers found that the marked plasmid 
spread quickly among chicken that were fed sub therapeutic levels of 
tetracycline. Even more remarkable was the discovery of the marked 
plasmid in E. coli isolated from chickens being fed tetracycline-feed in 
a second cage fifty feet away.167 These chickens had never been di-
rectly exposed to the E. coli containing the marked plasmid. The or-
ganisms with the marked plasmid were never found in the control 
group even though they had also been inoculated.l68 The conclusion 
of the author of these studies was that "long-term subtherapeutic an-
tibiotic use leads to selection and spread of transferable multiple-
resistance plasmids among chickens and man. "169 
Respected members of the scientific community have reviewed 
this data, and when their opinions are not constrained by the political 
process or economic pressures, their conclusions are not reassuring. 
The consensus appears to be that infections with resistant strains of 
bacteria could pose significant health risks. "For both nosocomial and 
community-acquired infections, the mortality, the likelihood of hospi-
talization, and the length of hospital stay were usually at least twice as 
great for patients infected with drug-resistant strains as for those in-
fected with drug-susceptible strains of the same bacteria. "170 In addi-
tion, these researchers conclude that "[a]lthough the adverse eco-
nomic and health effects of drug-resistant bacterial infections can 
only be roughly quantified, ... antimicrobial resistance is an impor-
tant health problem and an economic burden to society."I71 
The import of these observations is debated. Some respected re-
searchers continue to plead the case for a ban on the use of sub-
therapeutic doses of antibiotics if the antibiotic in question is or has 
analogues which are of potential value in treating infections in human 
165 Id. 




170 Scott D. Holmberg et aI., Health and Economic Impacts of Antimicrobial Resistance, 9 
REv. OF INFECTIOUS DISEASES 1065, 1065 (1987). 
171Id. 
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beings or if the antibiotic selects for multi-drug resistance.172 Consider 
the following, written in the summer of 1999 by Danish experts: 
Accumulating evidence now indicates that the use of 
glycopeptide avoparcin as a growth promoter has cre-
ated in food animals a major reservoir of Enterococcus 
faecium, which contains the high level glycopeptide re-
sistance determinant vanA .... Furthermore, glyco-
peptide-resistant strains, as well as resistance determi-
nants, can be transmitted from animals to humans. 
Two antimicrobial classes expected to provide the fu-
ture therapeutic options for treatment of infections 
with vancomycin-resistant enterococci have analogues 
among the growth promoters, and a huge animal res-
ervoir of resistant E. faecium has already been created, 
posing a new public health problem. l7lI 
The conclusion reached by these scientists was that "antimicrobial 
agents should not be used for growth promotion if they are used in 
human therapeutics or are known to select for cross-resistance to an-
timicrobial drugs used in human medicine. "174 
The Center for Science in the Public Interest has emphasized 
that any ban should include not only antibiotics which are themselves 
used in human treatment, but also drugs which select for cross-resis-
tance. They included the following warning in a 1998 report: 
For instance, the new antibiotic Synercid is one of the 
last hopes against deadly antibiotic-resistant blood-
stream infections. Although it has not yet been ap-
proved for use in humans, Synercid's value already has 
been compromised because resistance to one antibiotic 
can cause resistance to others. Thus, researchers at 
Wayne State University have found Synercid-resistant 
bacteria in turkeys that had been fed another antibi-
otic, virginiamycin, to promote growth.175 
172 Stuart B. Levy is one of the cadre of American experts leading this call. See generally, 
Levy, The Challenge, supra note 11; LEVY, ANTIBIOTIC PARADOX, supra note 44. 
17S Wegener, supra note 155, at 329. 
174Id. at 333. 
175 Lieberman, supra note 58. 
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On the other hand, there are other experts who acknowledge the 
concerns of public health authorities, infectious disease specialists 
and plasmid biologists,I76 but still conclude that "it is not clear 
whether the banning of these drugs as feed additives while allowing 
their use for therapeutic applications through prescription would 
represent any advantage."177 The debate between these two camps 
leads squarely to the issue of what should be done in response to the 
mounting scientific data which suggests a link between the sub-
therapeutic dosing of farm animals with antibiotics and the spread of 
antibiotic-resistant bacteria in human populations. 
IV. RECOMMENDATIONS FOR ,ApPROPRIATE REGULATION OF 
ANTIBIOTIC USAGE IN AGRICULTURE 
Although therapeutic dosing of farm animals (and human be-
ings) can also lead to the proliferation of resistant bacteria, sub-
therapeutic dosing regimens are particularly problematic, for a num-
ber of reasons. Not only is the sheer volume of antibiotics 
administered as prophylactics and growth promoters troubling, but 
this type of dosing creates an ideal situation for the selection and 
propagation of resistant bacteria.I78 In addition, an objective cost-
benefit analysis calls into question the decision to use antibiotics in 
livestock feed. 
On the benefit side of the equation, farmers have attributed 
lower costs of meat, eggs, and milk to sub therapeutic doses of antimi-
crobials in animal feed. I79 In 1999, the National Research Council's 
Committee on Drug Use in Food AnimalsI80 issued a report which in-
cluded a detailed economic analysis of the benefits of subtherapeutic 
dosing of livestock. The report concluded that the total cost of ban-
ning sub therapeutic use of antibiotics in agriculture would be be-
tween $1.2 billion to $2.5 billion per year.I81 While this number seems 
high, the number can be put in perspective by examining the ap-
proximate cost on a per capita basis. The National Research Council 
calculated that the average annual per capita cost to consumers of a 
176 See, e.g., Herbert L. DuPont & James H. Steele, The Human HeaUh Implication of the 
Use of AntimicrobialAgents in AnimalFeeds, 9(4) VETERINARY Q. 309 (1987). 
177 Id. at 320. 
85. 
178 See generaUy Levy, The Challenge, supra note 11. 
179 DuPont, supra note 177, at 309. 
180 See NAT'L RESEARCH COUNCIL, supra note 5; see also supra text accompanying note 
181 NAT'L RESEARCH COUNCIL, supra note 5, at 184. 
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ban on subtherapeutic drug use in animal agriculture would be in the 
range of $4.84 to $9.72 per year, with the effect being lowest for poul-
try ($1.09 to $2.20 for chickens, $0.27 to $0.56 for turkeys) and high-
est for cattle ($2.01 to $4.02).182 In terms of the price per pound in-
crease, the report estimated that the cost of chicken would increase 
somewhere in the range of $0.013-0.026 per pound; the cost of turkey 
would increase between $0.015-0.031 per pound; beef would cost be-
tween $0.03-0.06 more per pound; and pork would increase $0.03-
0.06 per pound.183 
In each case, the high end of the price range is based on the as-
sumption that there is no substitute for the subtherapeutic use of an-
tibiotics. However, there are several possible alternatives, including 
increased reliance on vaccinations (both those currently approved, 
and those that have yet to be developed/approved) and numerous 
changes to animal management practices that should reduce the eco-
nomic impact of banning the subtherapeutic use of antibiotics.184 No-
tably, improvements in animal hygiene and changes in animal 
confinement practices have the potential for significant improve-
ments in productivity which would help minimize the negative conse-
quences of reducing reliance on subtherapeutic doses of antibiot-
ics.185 
The National Resource Council has identified other potential 
economic benefits of allowing the subtherapeutic dosing of farm 
animals.186 These include: a slight advantage in export competitive-
ness,187 avoiding the personal and financial cost of producers who 
182 [d. at 184-85. These numbers are based on per capita costs, calculated by multiply-
ing the projected percentage increase in annual production costs by the retail price and 
the annual retail quantity sold per capita. [d. at 184. 
183 [d. at 185-86. The data is consistent with prior literature on the subject, notably 
1992 and 1994 studies that estimated a retail price increase for pork of $0.04 per pound. 
[d. at 186. 
184 SeeWORLD HEALTH ORG., supra note 81, at 15. 
185 Research from some European countries suggests that a shift to less intensive farm-
ing methods and improved animal hygiene can resolve many situations that create the 
need for antibiotic dosing. See, e.g., Witte, supra note 37, at 997; WORLD HEALTH ORG., 
supra note 81, at 15. 
186 This list was composed by the National Research Council. NAT'L RESEARCH COUN-
CIL, supra note 5, at 185-86. 
187 The extent to which American farmers need this edge is debatable, given that, ef-
fectiveJuly 1, 1999, the European Union banned four antimicrobials (bacitracin zinc, spi-
ramycin, virginiamycin and tylosin phosphate) considered to be important for treating 
infections in human beings. USDA REpORT, supra note 3, at 1. In addition, the European 
Union, Japan, Australia, and New Zealand have banned subtherapeutic use of penicillin 
and tetracyclines. Lieberman, supra note 58. 
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might be forced out of business if subtherapeutic use of antibiotics is 
prohibited, ISS higher profits for pharmaceutical companies,1s9 and 
reduced costs for eggs, dairy and pet-food,19o 
An additional potential benefit of allowing the subtherapeutic 
dosing of farm animals is the development of new animal drugs by the 
animal health industry. The 1999 National Research Council report 
identifies this as potentially "one of the most important consequences 
of such a ban."191 According to this source, approximately $355 mil-
lion was spent for internal research on animals drugs, and approxi-
mately $26 million was spent 'externally (principally in Universities) .192 
On the other hand, of these amounts, only 17% was allocated to food 
additives,193 so the significance of a ban on the use of antibiotics as 
additives at subtherapeutic levels is uncertain. Moreover, the potential 
benefits of such targeted research for human patients are uncertain, 
both because the outcome of research is always uncertain and because 
the very nature of this research is that it is directed towards use in the 
agricultural sector. 
On the cost side is the economic impact of increased antibiotic 
resistance. These numbers are also difficult to quantify. Researchers 
generally agree that the long-term, subtherapeutic dosing regimens 
contribute to the development of drug resistance in bacteria}94 The 
very nature of subtherapeutic antibiotic use makes the proliferation 
of antibiotic-resistant bacteria likely. "Unlike therapeutic doses used 
by veterinarians to treat infectious diseases in livestock, the small sub-
therapeutic doses used for growth promotion are administered for 
many months, sometimes years. This is a particularly dangerous com-
188 Note, however, that this does not necessarily mean that the small farmer will face an 
increasing risk of failure. Rather, the larger operations are more likely to use antibiotics to 
allow the use of more intensive confinement systems. See O'Brien, supra note 48, at 412-13. 
To some extent, limiting the use of subtherapeutic doses of antibiotics may help make 
smaller operations more competitive. 
189 The British experience, however, suggests that decreased profits due to diminished 
sales of restricted antibiotics can be at least partially offset by increased sales of antibiotics 
which are still available for feed use. See COMPTROLLER'S REpORT, supra note 68, at 22. 
Thus, if the ban on the subtherapeutic use of antibiotics in animals feed does not extend 
to all antibiotics, there is at least some possibility that this loss will be minimized. 
190 Presumably, these would be of the same general magnitude as the economic 
benefits associated with chicken, turkey, beef, and pork production. See supra text accom-
panying notes 180-184. 
191 NAT'L RESEARCH COUNCIL, supra note 5, at 186. 
192 [d. 
193 [d. 
194 See discussion supra Part III of this Article. Accord INST. OF MEDICINE, ANTIMICRO-
BIAL RESISTANCE: ISSUES AND OPTIONS (1998). 
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bination of antibiotic use that promotes antibiotic resistance. "195 As 
described in the preceding section of this Article, the extended use of 
subtherapeutic concentration of antibiotics can lead to the selection 
of multi-drug-resistant bacteria which then enter a common environ-
mental pool. From there, resistance determinants from various 
sources disseminate widely.196 The transfer occurs not only from one 
bacterium to another, but also from one animal host to another, and 
from one geographic location to others. The same resistance deter-
minants have been traced to many different genera of bacteria associ-
ated with animals, foods, and humans where they pose a threat to 
public health.197 
The costs associated with this phenomenon are staggering. The 
U.S. Office of Technology Assessment has estimated that the "minimal 
hospital costs" of five types of infections (e.g., surgical wound infec-
tion and pneumonia) due to antibiotic resistance were $4.5 billion 
per year.198 On a per person basis, the cost of antibiotic-resistance can 
be overwhelming. One source has reported that "[t]he cost of treat-
ing a patient with tuberculosis increases from $12,000 for a patient 
with a drug-susceptible strain to $180,000 for a patient with a multi-
drug-resistant strain. "199 Moreover, the economic cost may not be the 
most significant factor. The increase in drug-resistance also translates 
to an increase in human suffering, as death rates increase once resis-
tant bacteria begin to infect the human population.2oo 
Ironically, these costs have long been known or anticipated by 
various authorities. In 1969, a report commissioned by the English 
Parliament on the use of antibiotics in animal husbandry and veteri-
nary medicine recommended a ban on the subtherapeutic use of an-
195 Harrison, Part I, supra note 4, at 157. 
196 See discussion supra Part I of this Article. 
197 Levy, Antibiotic Use, supra note 39, at 616, 618. 
198 Khachatourians, supra note 47; LEVY, ANTIBIOTIC PARADOX, supra note 44. Accord 
Alexander Tomasz, Multipk-Antibiotic-Resistant Patlwgenic Bacteria-A Report on the Rockefeller 
University Workslwp, 330 NEW ENG.]. MED. 1247, 1248 (1994) ("Antibiotic-resistant patho-
gens contribute to the skyrocketing costs of inpatient care." Also citing the increase in cost 
to be "an estimated minimum of $4.5 billion" each year.) Other estimates of the cost of 
antibiotic resistance vary greatly. The National Foundation for Infectious Diseases esti-
mates an annual cost "as high as four billion dollars annually." USDA REpORT, supra note 3, 
at3. 
199 Lieberman, supra note 58. 
200 One website reports that "[e]ven with treatment, roughly half of all MDR-TB 
[multi-drug-resistant tuberculosis] patients die. This mortality rate matches that of patients 
with regular TB who received no medical care at all." OnHeal1h: Tuberculosis-Renewed Con-
cern, at http://onhealthnetworkcompany.com/conditions/resource/ conditions/item.681. 
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tibiotics in food producing animals.201 The call for a ban has been 
picked up by a growing number of scientists and medical experts in 
this country, and indeed, throughout the world. The Environmental 
Defense Fund, the Center for Science in the Public Interest, the Un-
ion of Concerned Scientists, the Public Citizen's Health Research 
Group and the Food Animal Concerns Trust have all asked the FDA 
to "end the use in livestock and poultry feeds of antibiotics that are 
used in ... [or] closely related to those used in human medicine.''202 
This position is supported by the World Health Organization, the 
CDC, the American Public Health Association, the Association of 
State and Territorial Health Officials, the Natural Resources Defense 
Council, the American Medical Women's Association, and other or-
ganizations.203 This Article seeks to join this call to action by bringing 
the debate into focus in the legal literature. 
The specific steps which seem justified at this time include limit-
ing the approval of new antibiotics for agricultural use, phasing out 
the subtherapeutic use of antibiotics in farm animals, regulating the 
therapeutic use of antibiotics in farm animals, and developing and 
disseminating information about alternatives to the use of antibiotics 
in livestock. Each of these suggestions deserves a more detailed con-
sideration. 
A. Antibiotic Approval Process 
No new antibiotics should be approved for agricultural use unless 
the drug sponsor can provide convincing evidence that the use of the 
drug in this manner presents no appreciable risk to human health. At 
a minimum, compliance with this standard would require proof that 
the antibiotic in question is not itself approved for use in human 
therapies, is not related to any such antibiotics or antibiotics that are 
under development for such purposes in such a manner that cross-
resistance is possible, and that use of the antibiotic does not select for 
multi-drug resistance. The burden of proof would be on the drug's 
sponsor, typically the manufacturer, to establish that these criteria 
have been met. In addition, it might be desirable to include a specific 
201 See COMPTROLLER's REpORT, supra note 68, at 9. 
202 Agricultural Use of Antibiotics Poses Major Public Health Threat, EDF NEWS RELEASE 
(Mar. 9, 1999), available at http://www.myworld.org/pubs/NewsReleases/1999/Mar/ 
d_agriculture.html [hereinafter EDF NEWS RELEASE]. 
203 See Petition to the U.S. Food and Drug Administration to Ban the Use of Certain Antibiotics 
in Livestock Feed: Executive Summary, (Sept. 28, 2000). available at http://www.cspinet.org/ 
reports/petition_antibiotic.htm. 
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requirement that the sponsor prove that the drug is effective for its 
intended purpose as a feed additive, but consideration of any such 
requirement is beyond the scope of this Article. 
This should be the first step in any appropriate response to the 
problem of drug resistance among bacteria because of evidence sug-
gesting that the problem is somewhat akin to Pandora's box. Once 
antibiotic resistance has emerged and becomes prevalent, it may not 
be easy to address the problem by retroactively revoking approval to 
use the drug at subtherapeutic levels. The National Research Council, 
for example, opined that "[o]nce an antibiotic has been introduced 
into animal management practice, either as a subtherapeutic feed ap-
plication or as a specific therapeutic drug, the emergence of some 
microbial resistance is highly probable, and cessation of antibiotic use 
does not significantly alter the pattern of resistance. "204 The primary 
evidence for this assertion appears to have come from the European 
Union, where a ban on many antibiotics has not been immediately 
effective in redressing the problem of drug resistance. 
The accuracy of the conclusion that a ban on the subtherapeutic 
use of antibiotics already approved for this purpose would be ineffec-
tive in addressing the problem is, however, open to debate. Other ex-
perts have concluded that it is possible to have an appreciable effect 
on the spread of antibiotic resistance by rescinding approvals for use 
of antibiotics in animals. 
Consider, for example, the evidence from Europe resulting from 
the relatively recent decision to ban the use of avoparcin as a food ad-
ditive for livestock.205 Prior to 1995, Denmark (and many other Euro-
pean Union countries) widely used avoparcin, a glycopeptide closely 
related to vancomycin, as a growth promoter. This use was accompa-
nied by a significant increase in the incidence of vancomycin-
resistance.206 Denmark, responding to public health concerns, 
banned the use of avoparcin as a food additive in 1995; Germany did 
the same in 1996, and the entire European Union banned its use in 
1997.207 This change resulted in "a marked reduction" in vancomycin-
204 NAT'L RESEARCH COUNCIL, supra note 5, at 159. 
205 For a discussion of glycopeptide resistance, and the problem of vancomycin-
resistance caused by the use of avoparcin in agriculture, see supra text accompanying notes 
130-136. 
206 Wegener, supra note 155, at 332. 
207 Id. 
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resistant bacteria in poultry in Denmark,208 and significant decreases 
in resistant bacteria in poultry and human beings in Germany.209 
This is the type of evidence which both suggests the wisdom of 
requiring convincing evidence before any decision to approve addi-
tional classes of antibiotics for use in livestock is made and supports 
the second part of the response suggested in this article-the system-
atic cessation of subtherapeutic dosing of animals with antibiotics. 
B. Phase Out Subtheraputic Use of Antibotics in Farm Animals 
Subtherapeutic use of antibiotics in farm animals should be 
phased out as rapidly as possible, unless the drug sponsor can provide 
convincing evidence that the use of the antibiotic in question presents 
no appreciable risk to human health. Ideally, this suggestion would be 
accomplished by the voluntary cessation of sub therapeutic dosing of 
livestock with antibiotics, but the use of antibiotics is so ingrained in 
this country that it will almost certainly be necessary to implement 
regulations phasing out the subtherapeutic use of antibiotics in agri-
culture.210 An exception to this requirement could be made, however, 
if the drug's sponsor proves that this type of use presents no risk to 
human health. 
If the antibiotic is not itself approved for use in human therapies, 
is not related to any such antibiotic or antibiotics that are under de-
velopment for such purposes in such a manner that cross-resistance is 
possible, and use of the antibiotic does not select for multi-drug resis-
tance, the health risks and associated costs described in this article 
would seem to be irrelevant to the question of whether subtherapeu-
tic doses should be permitted.21l However, even where the risks to 
human health are not appreciable, regulators might want to consider 
whether antibiotics approved for use in animals should also be re-
served for therapeutic treatment of livestock. Again, however, this 
suggestion is beyond the scope of this Article. 
The justification for prohibiting the subtherapeutic dosing of 
livestock is principally that the risk to human health is too great to 
permit the practice to continue. A senior researcher for the Environ-
208 Id. In 1995, 82% of poultry flocks tested positive for vancomycin-resistant bacteria. 
This percentage dropped to 12% by 1998. Id. 
209 Id. The incidence of resistance bacteria in poultry decreased from 100% in 1994 to 
25% in 1997, and in fecal samples from human beings it decreased from 12% in 1994 to 
3% in 1997. Id. 
210 See discussion supra Part II. 
211 See discussion supra Part IV. 
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mental Defense Fund, Rebecca Goldburg, phrased the problem this 
way: "Few Americans would deliberately choose to jeopardize the 
health of people for the sake of small economic advantages to the 
meat industry, yet, current FDA policies do just that. "212 The potential 
cost to consumers of a ban on this use of antibiotics, on a per capita 
basis, seems reasonable even if one assumes that there is no way to 
promote animal growth except through the subtherapeutic use of an-
tibiotics.213 
This approach is made even more reasonable when one looks at 
the range of available alternatives to the use of antibiotics at sub-
therapeutic levels:214 
Antibiotics as promoters of animal growth can be 
phased out gradually. Similar benefits can be gen-
erated by improving other aspects of animal care, 
such as hygiene. In the long run, an industrial in-
vestment in alternatives to antimicrobials for ani-
mal growth promotion should payoff in more 
efficient production of food animals as well as pro-
tection of the fragile resources that are critical to 
successful management of human infectious dis-
ease.215 
This conclusion seems supported by evidence from Sweden, 
where improvements in animal care and hygiene have largely offset 
any declines in growth rates caused by that country's decision to ban 
the use of antimicrobials as growth promoters.216 
C. Limit Short-Term Agricultural Use of Antibiotics 
Agricultural use of antibiotics should be limited to short-term use 
under the care of a licensed veterinarian unless the drug sponsor can 
show that the antibiotic in question is not used in human population, 
is not medically related to such drugs, and does not select for multi-
drug resistance in bacteria. Another aspect of the appropriate use of 
antibiotics in connection with the raising of livestock is to ensure that 
all antibiotics are administered under the supervision of a licensed 
veterinarian, in accordance with policies which require such use to be 
212 EDF NEWS RELEASE, sUfrra note 203. 
213 For a discussion of this issue, see sUfrra notes 182-184 and accompanying text. 
214 SeeWitte, sUfrranote 37, at 997. 
2151d. 
2161d. 
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short-term.217 The routine use of antibiotics should not be permitted 
even if it means that animal husbandry practices have to adapt. 
The justification for requiring antibiotics to be administered un-
der the supervision of a veterinarian is to insure compliance with ap-
propriate treatment regimens. If a farmer is permitted to dose his 
animals with antibiotics without any requirement that the decision to 
use such medicines be determined by a professional to be medically 
warranted, the problem of inappropriate use cannot be avoided. 
Thus, the veterinarian should act as a gatekeeper, in much the same 
way that a physician controls access of antibiotics to his or her human 
patients. 
D. Develop and Disseminate Information About Alternatives 
Information about alternatives to the use of antibiotics to main-
tain livestock health and growth rates should be developed and dis-
seminated among the agricultural and veterinary community. This 
suggestion is a matter of common sense. "Alternatives to antibiotic use 
for maintaining animal health and productivity-such as new vaccina-
tion techniques, improved animal nutrition, and genetic strategies--
must be sought. Existing alternatives should be implemented in a 
practical manner so that the appropriate uses of antibiotics and their 
effectiveness are maintained. "218 Once developed, every effort should 
be made to see that information about these alternatives is widely dis-
seminated. This will help reduce the potentially negative conse-
quences of limiting the subtherapeutic use of antibiotics. 
CONCLUSIONS 
It is clear that there is no easy solution to the problem of antibi-
otic resistance. The complexity of the problem is such that it will al-
ways be possible to question the data and raise doubts about the ap-
propriate response. For example, it can be argued that other practices 
(such as the misuse of prescription drugs among the human popula-
tion or the therapeutic use of antibiotics generally) are more impor-
tant in promoting the spread of antibiotic-resistant bacteria. In addi-
tion, the adequacy of the existing scientific data can be attacked on 
the basis that there are too few studies which look at dosing levels, or 
217 Admittedly, this suggestion will probably require expenditures to ensure that vet-
erinarians are educated about the risks of antibiotic resistance and the appropriate use of 
antibiotics. Seediscussion supra Part IV. 
218 NAT'L RESEARCH COUNCIL, supra note 5, at 9. 
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which examine the question of how varying treatment regimes are 
related to the development of antibiotic resistance. It is also true that 
many antibiotics have not been studied extensively, and so we do not 
know for sure if their use promotes antibiotic resistance. It can even 
be argued that the evidence about whether use of antibiotics in ani-
mals causes significant increases in human morbidity or mortality is 
inconclusive. Finally, it can be asserted that banning the subtherapeu-
tic dosing of animals has not been proven as an appropriate or effec-
tive response to the problem. 
All of these objections have some merit, but none of them come 
close to providing convincing evidence that the subtherapeutic use of 
antibiotics in livestock feeds is prudent or wise. They do, however, 
tend to make one focus on the larger picture. Realistically speaking, it 
is clear that the use of subtherapeutic levels of antibiotics for farm 
animals is only part of the picture. Complicating things significantly is 
the use and abuse of prescription antibiotics by physicians who over-
prescribe and patients who fail to complete their prescribed treat-
ment regimens. These patterns of behavior in the human population 
undoubtedly are a significant factor in the spread of antibiotic resis-
tance. Sources estimate that as many as one third of all prescriptions 
in this county are unnecessary or inappropriate,219 and there are no 
reliable statistics on how many patients fail to take all of a prescribed 
course of antibiotics or dose themselves or others with the left-over of 
a prior course of treatment. Thus, a comprehensive solution to the 
problem of antibiotic resistance necessarily includes steps to address 
this problem. Public and physician education and increased reliance 
on diagnostic tests such as culturing of infections to determine which, 
if any, antibiotics are appropriate220 would be desirable components of 
a response to the over-prescription of antibiotics in the human popu-
lation. Other steps might also be appropriate.221 
%19 The Centers for Disease Control and Prevention estimate that of the approximately 
150 million antibiotic prescriptions written by physicians on an outpatient basis each year, 
as many as 50 million may be unnecessary. Levy, The Challenge, supra note 11, at 51. 
no In today's economic climate, this would also necessarily require that health mainte-
nance organizations and private insurance companies cover the cost of diagnostic tests to 
assure appropriate use of antibiotics. This might also require steps to encourage physicians 
to perform strep tests in their offices, such as exempting rapid strep tests from require-
ments imposed by the Clinical Laboratory Improvement Amendments of 1988 (Pub. L. 
No. 100-578, 102 Stat. 2903 (1988), relevant provisions codified at 42 U.S.CA. § 263a 
(1998). 
2l!1 For possible regulatory responses to this problem, see Misocky, supra note 7, at 737, 
and Markow, supra note 9, at 545-49. 
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The recent advent of increasingly popular "antibiotic" household 
and personal cleansers has also been identified by some as another 
threat to the continued viability of antibiotics.222 Certainly, to the ex-
tent that such products cross-select for resistant bacteria, they also 
contribute to the problem. Again, public education might suffice, but 
it might also be desirable or necessary to regulate the use of antimi-
crobial products that have the potential to select for cross-resistant 
strains of bacteria. 
There are also additional problems with the agricultural use of 
antibiotics beyond those identified in this Article. First, there is the 
questionable practice of allowing antibiotics to be used as pesticides. 
Between 40,000 and 50,000 pounds of antibiotics are sprayed on fruit 
trees each year.223 While this amount may seem trivial in comparison 
with the millions of pounds of antibiotics used as animal food addi-
tives, it has also been identified as a potential factor in the spread of 
resistance among bacteria.224 Again, it seems prudent to ban this use 
of antibiotics unless the proponent can provide convincing evidence 
that there is no risk to human health from this application. 
Similarly, the practice of allowing farmers to choose therapeutic 
dosing levels of antibiotics for their livestock is also questionable.225 
While existing data may fall short of what would be sufficient to justify 
a ban on the therapeutic use of antibiotics among livestock, there cer-
tainly seems to be enough data to support a requirement that such 
use be supervised by a licensed veterinarian. When antibiotics were 
first made available to the human population, there was no require-
ment that the patient obtain a physician's prescription.226 The prac-
tice of self-closing quickly promoted the spread of resistant bacteria, as 
people used antibiotics inappropriately.227 Similar patterns might be 
expected for farmers. The risk that farmers will medicate livestock 
when there is no medical justification for antibiotic use should be lim-
44. 
222 Levy, The Challenge, supra note 11, at 48. 
223 Lieberman, supra note 58. 
224 Id.; accord Khachatourians, supra note 47; LEVY, ANTIBIOTIC PARADOX, supra note 
225 Lieberman, supra note 58. "Currently, many antibiotics, such as tylosin, penicillin, 
tetracycline, and gentamicin, are available over the counter to farmers to administer at 
their discretion to livestock by injection, orally, and as feed additives." Id. 
226 Harrison, Part 1, supra note 4, at 151. 
227 Id. at 152. 
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ited if antibiotics are available only when supervised by licensed pro-
fessionals.228 
In addition, it should be made clear through the regulatory pro-
cess that the only antibiotics available for mass-dosing (Le., of the en-
tire herd or flock) will be those which are not used by human beings, 
are not medically related to drugs used by human beings, and do not 
select for multi-resistance. Otherwise, animal antibiotic use should be 
limited to the treatment of individual animals. This would effectively 
prevent the dosing of large numbers of healthy animals, which 
significantly increases the likelihood that resistant strains of bacteria 
will spread among animal populations. 
It should also be acknowledged that the failure of the govern-
ment (which provides funding for a great deal of research, especially 
at the University level) and pharmaceutical companies to anticipate 
the speed with which bacteria would become resistance to new treat-
ments is a contributing factor in the seriousness of the problem of 
antibiotic resistance.229 Various surveys have noted that there are es-
sentially no new antibiotics on the immediate horizon.230 Because of 
the time and expense associated with the development of new treat-
ments,m this means that the rapid proliferation of resistant bacteria is 
of considerable concern because there is no quick fix for this prob-
lem. Moreover, if new drugs are found and developed, the potential 
for cross-resistance may mean that they will be of limited usefulness, 
as well.232 Even with these limitations, however, pharmaceutical com-
panies should be encouraged to increase their efforts to develop new 
228 To encourage the appropriate treatment of sick animals, the FDA or USDA should 
develop and promulgate a symptom-based formulary describing appropriate treatment 
regimens for common infections. See discussion supra Part IV. 
229 Levy, The Chalknge, supra note 11, at 52. Apparently, most pharmaceutical compa-
nies focused on the development of treatments for chronic ailments rather than on devel-
oping new antibiotics. Whatever the cause, however, the current situation (where we have 
no new general antibiotics in the pipeline) is not healthy. 
Id. 
i!O Harrison, Part I, supra note 4, at 155. 
[T]he pipeline of new antibacterial drugs is essentially empty, the result of a 
prolonged lack of research interest and funding. A survey of large US and 
Japanese pharmaceutical companies ... found that half of the companies ei-
ther reduced or phased out their antibacterial programs in the last decade 
m The cost of development of a new antibiotic has been estimated to approach $300 
million and twelve years of time. Id. at 156. 
252Id. 
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classes of antibiotics and new approaches to the problem of antibiotic 
resistance. 
Finally, the failure of the agricultural community to develop or 
accept alternatives to sub therapeutic dosing of animals makes the 
problem which this Article addresses politically sensitive. Consider the 
efforts of the FDA in the 1970s to ban certain agricultural uses of an-
tibiotics.233 Following a task force's recommendations, the FDA prom-
ulgated proposed rules which would remove penicillin and tetracy-
clines from the list of antibiotics approved for use as food additives for 
disease prevention and growth promotion. The proposed rules would 
also have restricted the use of antibiotics in animals to short-term 
therapeutic use prescribed by a veterinarian, unless the drug's spon-
sor submitted data establishing that the use for agricultural purposes 
would pose no risk to human health. The proposed rules prompted 
vigorous opposition from agri-business and farm-state legislators in 
Congress, and the proposed limits on the agricultural use of antibiot-
ics were not implemented.234 
The problem posed by the politics of the situation probably also 
requires a multifaceted response. It would be foolish not to recognize 
that the political acceptability of the response suggested here depends 
on a number of factors. The first step is education of the public about 
the dangers of antibiotic resistance. Realistically, a political solution 
will only emerge if it is politically acceptable. This requires an edu-
cated and concerned population. 
In addition, education of the agricultural community about the 
risks associated with the routine use of subtherapeutic doses of antibi-
otics would certainly help, as would education about alternatives to 
this practice, such as increased reliance on vaccinations and changes 
in animal hygiene and confinement practices. The U.S. Department 
of Agriculture can playa significant role in the education process and 
in seeing that sufficient resources are applied to developing alterna-
tives to the routine use of antibiotics in farm animals. 
Taken as a whole, the factors discussed briefly here make it obvi-
ous that the problem of antibiotic resistance is incredibly complex. 
The complexity of the situation does not, however, diminish the di-
mensions of the problems posed by antibiotic resistance. Whether or 
not subtherapeutic dosing of animals is the major cause of the prob-
233 For a general discussion of this issue, see Lieberman, supra note 58; see also supra 
notes 73-74 and accompanying text. 
234 Lieberman, supra note 59. 
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lem, it is clearly a cause. Whether or not banning such use will solve 
the problem by itself is not the real question. The question is whether 
the existing evidence suggests that this is an appropriate and reason-
able part of the solution. 
Our reading of the evidence suggests that it is. 

